Skip to content

Clinical trials

Oligospermia trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Oligospermia Country / region: China Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20161
20171
20212
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status3
Completed2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Reproductive & Genetic Hospital of CITIC-Xiangya2
Staidson (Beijing) Biopharmaceuticals Co., Ltd2
Jinling Hospital, China1
Livzon Pharmaceutical Group Inc.1
The Third Affiliated Hospital of Guangzhou Medical University1
Zhujiang Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Oligospermia8
Azoospermia3
Asthenozoospermia2
Infertility2
Infertility, Male2
Teratozoospermia1

Trials

Showing 26 to 8 of 8. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.